argenx NV ADR

Yahoo Finance • 7 days ago

Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO

(RTTNews) - The biotech industry witnessed several key events this week, including major FDA approvals, acquisitions, pivotal clinical trial results and setbacks. • A series of FDA approvals were announced during the week, with GSK, Haloz... Full story

Yahoo Finance • 9 days ago

Here Are Thursday’s Top Wall Street Analyst Research Calls: Digital Realty, GE Vernova, Micron Technology, Merck & Co., Rivian, United Airlines, and More

mezzotint / Shutterstock.com Quick Read Stocks took another beating on Wednesday amid concerns over the AI/Data Center trade. While inflation appears somewhat contained, any spike in the headline number today could send markets lower. Ho... Full story

Yahoo Finance • 12 days ago

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

European equities traded in the US as American depositary receipts kicked off the week higher late M PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 25 days ago

ARGX Quantitative Stock Analysis - Benjamin Graham

Below is Validea's guru fundamental report for ARGENX SE - ADR (ARGX). Of the 22 guru strategies we follow, ARGX rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology... Full story

Yahoo Finance • 25 days ago

European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading

European equities traded in the US as American depositary receipts were higher late Tuesday morning, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 29 days ago

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gain 4% for Week

European equities traded in the US as American depositary receipts were trending higher late Friday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • last month

argenx Announces Results of Extraordinary General Meeting of Shareholders

November 18, 2025–10:01 PM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the results of it... Full story

Yahoo Finance • last month

Frank Sands Reduces Stake in DexCom Inc by 50.4%, Impacting Portfolio by -1.25%

This article first appeared on GuruFocus. Insightful Analysis of Frank Sands (Trades, Portfolio)' Third Quarter 2025 13F Filing Warning! GuruFocus has detected 7 Warning Signs with NVDA. Is NVDA fairly valued? Test your thesis with our f... Full story

Yahoo Finance • last month

Here’s Why argenx SE (ARGX) Rose in Q3

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an environment of shifting monetary policy, stabiliz... Full story

Yahoo Finance • 2 months ago

Argenx Gains Health Canada Approval For Vyvgart SC As Monotherapy In CIDP

(RTTNews) - argenx SE (ARGX), Wednesday, announced that Health Canada has issued a Notice of Compliance authorizing VYVGART SC as a monotherapy for the treatment of adult patients with active chronic inflammatory demyelinating polyneuropat... Full story

Yahoo Finance • 2 months ago

argenx SE (ARGX) Rose due to Increased Sales of its Vyvgart Medication

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional Shares) in the quarter, compared to a... Full story

Yahoo Finance • 2 months ago

argenx SE beats top-line and bottom-line estimates; reaffirms FY25 outlook

* argenx SE press release [https://seekingalpha.com/pr/20285593-argenx-reports-third-quarter-2025-financial-results-and-provides-business-update] (ARGX [https://seekingalpha.com/symbol/ARGX]): Q3 GAAP EPS of $5.18 beats by $0.83. * Rev... Full story

Yahoo Finance • 2 months ago

argenx Reports Third Quarter 2025 Financial Results and Provides Business Update

$1.13 billion in third quarter global product net sales On track to submit seronegative gMG sBLA by year-end and report ADAPT-OCULUS results in 1H26 – supporting pursuit of broadest MG label of any biologic Five registrational study read... Full story

Yahoo Finance • 2 months ago

argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients

VYVGART demonstrated clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes in ADAPT SERON, supporting broad role of pathogenic IgGs in disease activityFinal ADAPT SC+ results show ~60% of VYVGART gMG patients achieved... Full story

Yahoo Finance • 2 months ago

Citi Remains Bullish on Argenx SE (ARGX)

Argenx SE (NASDAQ:ARGX) is one of the most profitable biotech stocks to buy. Citi analyst Samantha Semenkow maintained a Buy rating on Argenx SE (NASDAQ:ARGX) on October 23 and set a price target of $1,041. Argenx SE (NASDAQ:ARGX) also rec... Full story

Yahoo Finance • 2 months ago

Should You Be Confident in Argenx SE’ (ARGX) Long-Term Profit Cycle?

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equity markets continued their strength in the third quarter, e... Full story

Yahoo Finance • 2 months ago

argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session

Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential to treat broad set of myasthenia gravis patientsReal-world evidence and long-term data reinforce VYVGART’s sustained impact on patient outcomesMore than 40... Full story

Yahoo Finance • 3 months ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

European equities traded in the US as American depositary receipts were moving higher Wednesday morn PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025

October 3, 2025 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the Extraordinary Gen... Full story

Yahoo Finance • 3 months ago

High Growth European Tech Stocks To Watch September 2025

The European market has shown resilience, with the pan-European STOXX Europe 600 Index rising by 1.03% amid expectations of a U.S. Federal Reserve interest rate cut, signaling optimism in the region's economic outlook despite some mixed si... Full story